KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Retained Earnings: 2010-2024

Historic Retained Earnings for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to -$951.8 million.

  • TherapeuticsMD's Retained Earnings rose 0.03% to -$951.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$951.8 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$951.8 million for FY2024, which is 0.23% down from last year.
  • Per TherapeuticsMD's latest filing, its Retained Earnings stood at -$951.8 million for FY2024, which was down 0.23% from -$949.6 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Retained Earnings ranged from a high of -$878.9 million in FY2020 and a low of -$1.1 billion during FY2021.
  • Over the past 3 years, TherapeuticsMD's median Retained Earnings value was -$949.6 million (recorded in 2023), while the average stood at -$946.9 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first declined by 26.39% in 2020, then climbed by 10.65% in 2022.
  • Over the past 5 years, TherapeuticsMD's Retained Earnings (Yearly) stood at -$878.9 million in 2020, then dropped by 19.62% to -$1.1 billion in 2021, then grew by 10.65% to -$939.4 million in 2022, then dropped by 1.09% to -$949.6 million in 2023, then decreased by 0.23% to -$951.8 million in 2024.